Cancer news
The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
Liver Cancer
Gentle regular exercise could reduce the risk of liver cancer in mice
A team of Cancer Research UK-funded scientists have been investigating the role of exercise in reducing the risk of liver cancer in mice
Liver cancer deaths climb by around 50% in the last decade
Liver cancer deaths have increased by around 50% in the last decade and have tripled since records began
Obese people outnumber smokers two to one
People who are obese now outnumber people who smoke two to one in the UK, and excess weight trumps smoking as the leading cause of four different cancer types.
Three cancer drugs cleared for NHS funding in Scotland
Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.
Clinical trial launches to develop breath test for multiple cancers
Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage.
Targeted cancer drug made available for some NHS liver cancer patients
A targeted cancer drug will now be available for some adults with advanced liver cancer on the NHS.
Liver cancer: UK’s fastest rising cause of cancer death to be tackled
A joint UK and European research project launches today to combat liver cancer, which is the fastest rising cause of cancer death in the UK.
Drug could protect children from hearing loss after chemo
New trials results show that a drug can reduce hearing loss in children treated with the chemo drug cisplatin. We talk to the lead researcher, Dr Penelope Brock.
Cancer blood tests and learning from HIV – our latest Pioneer Awards
Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.
3 in 4 Cancer Drugs Fund treatments now available on NHS
Three quarters of the drugs previously only accessible to patients via the Cancer Drugs Fund (CDF) are now approved on the NHS.